Announced Mon, 29 Jun · 16:32 IST
Trading window closed for Q1 FY27 results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.5%1-day move
₹224.00
prior close
₹225.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.5+5.4+15.2+27.2+24.1+13.4+16.1———
Up moveDown movePending
AI summary
Samrat Pharmachem has closed its trading window from July 1, 2026 until 48 hours after the declaration of unaudited financial results for Q1 FY27 (quarter ended June 30, 2026). All designated persons and their immediate relatives cannot trade in the companys shares during this period. This is a routine compliance filing under SEBI Insider Trading Regulations.
Likely market impact
Routine regulatory compliance. No material impact on shareholders. Q1 FY27 results expected soon.